At molecular level, activating mutations in epidermal growth factor receptor (EGFR) are the most frequent genetic mutation driving cancer cell proliferation and tumor malignancy in East Asians never-smoker NSCLC patients, especially in females (3, 4). This evidence concerns the gene EGFR and non-small cell lung carcinoma.